INMIS 2010 Programme
Day 1
26 March 2010 Friday 08.45-09.00 Welcome Remarks 09.00-10.00 Chair: Kathryn EDWARDS Burden of neonatal/early infections that need to be prevented and rationale expanded neonatal immunization Kim MULHOLLAND
Pharmacoeconomic evaluation of neonatal, infant and maternal vaccination programmes Philippe BEUTELS
10.00-11.10 BASIC NEONATAL IMMUNOLOGY Chair: Yıldız CAMCIOGLU
Development of the innate immune system of the human newborn Tobias KOLLMAN
Development of the adaptive immune system in early life Arnaud MARCHANT
Mucosal Immunology in Neonatal Period Pearay OGRA 11.10-11.20 Coffee Break 11.20-12.30 EARLY LIFE VACCINOLOGY-1 Chair: Paul HEATH Duration of passively acquired maternal antibodies in infants Elke LEURIDAN
Determinants of humoral immune response against polysaccharide vaccines in newborns Mustafa AKKOYUNLU
Developmental Biology of the Innate Immun System Implications for Neonatal and Infant Vaccine Development Ofer LEVY
12.30-14.00 Lunch 14.00-15.30 EARLY LIFE VACCINOLOGY-2 Chair: Peter McINTYRE, Selim BADUR Microorganism specific neonatal immunity: Group B streptococcus as a paradigm Philipp HENNEKKE
Vaccine strategies to enhance immune responses in neonates Geert Vanden BOSSCHE
Immunization of the premature infants Kadriye YURDAKOK
Safety issues associated with early immunization Neal HALSEY 15.30-16.00 Coffee Break 16.00-17.30 MATERNAL IMMUNIZATION: adolescents to adults Chair: Esin ŞENOL
Adolescent immunization schedule Mustafa HACIMUSTAFAOGLU
Prospects for global control of HPV disease Marc KANE
Adult immunization schedule Esin SENOL
Immunization during pregnancy: recommendations and safety issues Wolfgang MAURER
DAY 2
27 March 2010 Saturday 09.00-10.40 INFLUENZA and PANDEMIC H1N1 Chair: Pierre van DAMME
Influence of maternal influenza antibody on infant antibody response Janet ENGLUND
Influenza vaccines during infancy Timo VESIKARI
H1N1 infections during pregnancy Peter McIntyre
H1N1 vaccines during pregnancy Kathryn EDWARDS
H1N1 pandemics: lessons to be learned and WHO perspective Pierre van Damme
10.30-11.00 Coffee Break 11.00-12.10 PERTUSSIS DIPHTERIA TETANUS Chair: Vytautas USONIS Pertussis, Tetanus, and Diphtheria vaccine in adolescents and adults Vytautas USONIS
Prevention of Pertussis and Tetanus Among Pregnant and Postpartum Women Trudy V. MURPHY
Infant immune system to pertussis and pertussis vaccine during newborn period Peter McINTYRE 13.00-14.00 Lunch – GSK Satellite Symposium
14.00-15.30 IMMUNIZATION PRACTICE IN EARLY LIFE Chair: Necmi AKSARAY Global control of Hepatitis B with vaccine Pierre van DAMME
BCG vaccine Mustafa BAKIR
Rotavirus vaccination in early newborn period and in infancy Timo VESIKARI 15.10-15.30 Coffee Break 15.30-16.30 RSV INFECTION Chair: Janet ENGLUND- Murat YURDAKOK RSV infections: epidemiology, pathogenesis and clinical findings
RSV infection: prevention Nuran SALMAN 16.30-17.00 Coffee Break
17.00-18.15 MENINGOCOCCAL INFECTIONS Chair: Emre ALHAN Meningococcal vaccines in newborns, children Mehmet CEYHAN
Meningococcal vaccines in adults and pregnancy period Ziad Memish
Day 3
28 March 2010 09.00-10.40 PNEUMOCOCCAL INFECTIONS Chair: Javier GARAU- Mehmet CEYHAN
New pneumococcal conjugate vaccines Susanna ESPOSITO
Pneumococcal vaccine in adults Murat AKOVA
10.40-11.00 Coffee Break
11.00-12.00 Potential new vaccines Chair:
Group B streptococcal vaccines Paul HEATH
MRSA vaccines Robert DAUM
Cytomegalovirus vaccines Mark R. SCHLEISS